New tool aims to lift the fog around life with a heart pump

NCT ID NCT06823583

Recruiting now Knowledge-focused Sponsor: Bryan Heart Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a tool designed to help people with advanced heart failure understand what life is like after getting a ventricular assist device (VAD), a mechanical heart pump. Researchers created the tool based on surveys from previous VAD patients about their quality of life at different time points. The study will enroll 10 patients and their clinicians to see if the tool accurately reflects real patient experiences. It does not test a drug or device, but rather a way to improve patient education and shared decision-making.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this tool could help patients and doctors make more informed decisions about VAD implantation by clarifying what to expect long-term.
What could go wrong: This is a very small feasibility study (10 participants) testing only the tool's accuracy, not its impact on outcomes. The tool may not improve patient experience or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED HEART FAILURE ANTICIPATORY GUIDANCE VENTRICULAR ASSIST DEVICE

Contacts and locations

Locations

Advocate Aurora Health
NOT_YET_RECRUITING

Milwaukee, Wisconsin, 53215, United States
Bryan Heart
RECRUITING

Lincoln, Nebraska, 68506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.